Laboratoire de Recherche sur lArthrite et lInflammation, Department of Medicine, Faculty of Medicine, Centre Hospitalier de lUniversité Laval, Sainte-Foy, Québec, Canada
Correspondence: Dr André Beaulieu, Laboratoire de Recherche sur lArthrite et lInflammation, Centre Hospitalier de lUniversité Laval, 2705 Boul. Laurier, Sainte-Foy, Québec, Canada G1V 4G2. E-mail: andre.beaulieu{at}crchul.ulaval.ca
In our study of the modulation of the expression of inflammation-related genes in neutrophils, we have found a gene called CLECSF6 (C-type lectin superfamily 6). CLECSF6 expresses two mRNA species at low levels in resting neutrophils. Here, we describe for the first time the sequence of the short mRNA version. It lacks amino acids that are likely to affect the functionality of its protein product. GM-CSF, IL-3, IL-4, and IL-13 caused an accumulation of the short CLECSF6 mRNA in neutrophils. The surface expression of the CLECSF6 protein was reduced by TNF-
, IL-1
, LPS, and Matrigel®. CLECSF6 bears the immunoreceptor tyrosine-based inhibition motif (ITIM) involved in signal transduction resulting in the inhibition of leukocyte activation. We propose that some neutrophil activators modulate the expression of CLECSF6 at the mRNA (GM-CSF, IL-3, IL-4, and IL-13) or protein (TNF-
, IL-1
, LPS, and Matrigel®) levels in ways that block ITIM-based transduction of anti-inflammatory signals and therefore promote inflammation.
Key Words: inhibition receptor mRNA protein cytokine
This article has been cited by other articles:
![]() |
C Eklow, D Makrygiannakis, L Backdahl, L Padyukov, A-K Ulfgren, J C Lorentzen, and V Malmstrom Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells Ann Rheum Dis, December 1, 2008; 67(12): 1742 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lambert, C. Gilbert, M. Richard, A. D. Beaulieu, and M. J. Tremblay The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways Blood, August 15, 2008; 112(4): 1299 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verbrugge, T. de Ruiter, C. Geest, P. J. Coffer, and L. Meyaard Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation J. Leukoc. Biol., April 1, 2006; 79(4): 828 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, K. Yamamoto, T. Kohno, N. Hironaka, K. Yasui, C. Kojima, H. Mukae, J.-i. Kadota, S. Suzuki, K. Honma, et al. Active repression of IFN regulatory factor-1-mediated transactivation by IFN regulatory factor-4 Int. Immunol., November 1, 2005; 17(11): 1463 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Scotton, F. O. Martinez, M. J. Smelt, M. Sironi, M. Locati, A. Mantovani, and S. Sozzani Transcriptional Profiling Reveals Complex Regulation of the Monocyte IL-1{beta} System by IL-13 J. Immunol., January 15, 2005; 174(2): 834 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. J. Marshall, J. A. Willment, H.-H. Lin, D. L. Williams, S. Gordon, and G. D. Brown Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes J. Biol. Chem., April 9, 2004; 279(15): 14792 - 14802. [Abstract] [Full Text] [PDF] |
||||